Resflu-S 250 Capsules – Fluticasone Propionate 250 Mcg + Salmeterol 50mcg
Resflu – S 250 DPI Caps Is A Dual-action Dry Powder Inhaler (Dpi) Therapy Designed For The Effective Management Of Asthma And Chronic Obstructive Pulmonary Disease (Copd). Combining The Potent Anti-inflammatory Properties Of Fluticasone Propionate With The Long-acting Bronchodilating Action Of Salmeterol, This Formulation Offers Sustained Symptom Control And Improved Respiratory Function.
Composition:
- Fluticasone Propionate 250 mcg: A corticosteroid that reduces airway inflammation and prevents flare-ups.
- Salmeterol 50 mcg: A long-acting beta-2 agonist (LABA) that relaxes airway muscles for 12-hour relief.
Key Features of RESFLU – S 250 DPI CAPS
- Dual Mechanism of Action: Targets both airway inflammation and bronchoconstriction for comprehensive respiratory support.
- Long-Lasting Relief: Provides up to 12 hours of symptom control, reducing the frequency of inhaler use.
- Convenient DPI Format: Ensures precise dosing and easy administration for enhanced patient compliance.
